Physician profile
Ashish Gupta
NPI 1982782470
$1,078,862.28
in general payments reported to CMS, 2019-2025
61 companies · $168K in 2025
The $168K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184K · 2020: $58K · 2021: $104K · 2022: $197K · 2023: $202K · 2024: $167K · 2025: $168K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $355K · Travel and Lodging: $93K · Food and Beverage: $45K · Honoraria: $23K · Consulting Fee: $20K · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $354,927.00 |
| Travel and Lodging | $93,007.09 |
| Food and Beverage | $44,977.08 |
| Honoraria | $23,400.00 |
| Consulting Fee | $19,966.84 |
| Education | $299.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $475,241.81 | 2019-2025 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $202,055.86 | 2019-2025 | |
| Boston Scientific Corporation | $178,028.87 | 2019-2025 | Watchman Access System, Watchman Flx, Rhythmia Mapping System |
| Impulse Dynamics (USA) INC. | $84,013.87 | 2021-2025 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $66,588.45 | 2022-2025 | Winrevair, Verquvo |
| Abbott Laboratories | $20,882.53 | 2019-2025 | Cardiomems, Confirm Rx, Mitraclip |
| Cvrx, INC. | $11,197.03 | 2022-2025 | Barostim Neo System |
| Penumbra, INC. | $5,608.20 | 2022-2025 | Indigo System |
| Medtronic, INC. | $4,357.24 | 2021-2025 | Linq II, Micra, Corevalve Evolut R |
| Atricure, INC. | $3,790.56 | 2023 | |
| United Therapeutics Corporation | $3,724.88 | 2019-2021 | |
| Medtronic Vascular, INC. | $3,287.10 | 2019-2020 | |
| Inari Medical, INC. | $2,454.03 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $2,022.85 | 2019-2025 | Ecc Solutions, (Ck6) Holter, (5044) Mcot |
| Novartis Pharmaceuticals Corporation | $1,562.36 | 2019-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,383.84 | 2019-2025 | Lifevest |
| Amgen INC. | $1,095.76 | 2019-2025 | Repatha, Repatha |
| Biosense Webster, INC. | $926.24 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $897.46 | 2020-2025 | Farxiga |
| Heartflow, INC. | $892.95 | 2022-2025 | |
| Edwards Lifesciences Corporation | $839.50 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Regeneron Healthcare Solutions, INC. | $794.38 | 2019 | |
| Cardiva Medical, INC. | $735.25 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Sanofi-Aventis U.S. LLC | $612.89 | 2019-2023 | |
| Novo Nordisk INC | $578.88 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Amarin Pharma, INC. | $470.49 | 2019-2021 | |
| Johnson & Johnson Health Care Systems INC. | $403.34 | 2023-2025 | Opsumit, Uptravi |
| Tactile Systems Technology INC | $346.11 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $333.24 | 2019-2025 | Camzyos |
| Itamar Medical INC | $305.99 | 2022-2024 | Watchpatone |
| Janssen Pharmaceuticals, INC | $281.98 | 2019-2023 | Xarelto |
| Inspire Medical Systems, INC. | $278.28 | 2020-2025 | Inspire |
| Regeneron Pharmaceuticals, INC. | $253.48 | 2019 | |
| Pfizer INC. | $250.03 | 2019-2024 | |
| Ensodata, INC. | $246.81 | 2025 | |
| Alnylam Pharmaceuticals INC. | $225.20 | 2020-2022 | |
| Esperion Therapeutics, INC. | $207.87 | 2020-2023 | Nexletol |
| Kestra Medical Technology Services, INC. | $202.06 | 2022-2025 | Assure Wcd |
| Janssen Scientific Affairs, LLC | $183.52 | 2019 | |
| Biotronik INC. | $154.95 | 2019-2020 | |
| Abiomed | $125.98 | 2020-2022 | |
| Acutus Medical, INC. | $125.65 | 2023 | |
| Medtronic Minimed, INC. | $115.60 | 2019 | |
| Sandoz INC. | $107.00 | 2019-2025 | Treprostinil |
| Endologix LLC | $100.45 | 2024 | Afx2 Bifurcated Endograft System |
| Zoll Respicardia, INC. | $96.91 | 2024 | Remede System |
| Travere Therapeutics, INC. | $75.00 | 2019 | |
| Silk Road Medical, INC. | $51.89 | 2021 | |
| Inspiremd Ltd | $50.51 | 2025 | Cguard Prime Carotid Stent System |
| Bardy Diagnostics, INC. | $45.00 | 2021-2022 | |
| Astellas Pharma US INC | $43.12 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $38.96 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $33.38 | 2024 | Arcalyst |
| Chiesi USA, INC. | $29.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.16 | 2019 | |
| Endotronix, INC. | $24.06 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Beone Medicines USA, INC. | $20.00 | 2025 | Brukinsa |
| Amryt Pharma Holdings Ltd | $17.79 | 2021 | |
| Csl Behring | $15.90 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.